- This event has passed.
Emergency Preparedness, Ethics & Equity Series: How Can We Ensure Equitable Access to COVID-19 Treatment? (Virtual)
June 2, 2020 @ 2:00 pm - 3:00 pm
Hosted by the Gillings School of Global Public Health, the series explores how e can continue to foster inclusive excellence and health equity during the most turbulent of times. Speakers explore ways to consistently apply culturally relevant, ethical and equitable decision making so that the most vulnerable among us are not left further disenfranchised post-COVID-19. This webinar will be moderated by Matthew Chamberlin, director of Communications and Marketing, UNC Gillings School of Global Public Health. Panelists will include:
- Ralph S. Baric, PhD, William R. Kenan, Jr. Distinguished Professor, Epidemiology, Professor, Microbiology and Immunology, UNC Gillings School of Global Public Health
Dr. Baric has spent the pat three decades as a world leader in the study of coronaviruses, warning that the emerging coronaviruses represent a significant and ongoing global health threat. His team in the Baric Lab has been working to accelerate the development of a promising new drug, remdesivir, which has been shown to inhibit multiple coronaviruses. In collaboration with industry partner Gilead Sciences, Inc., this drug is currently in clinical trials to reverse COVID-19 disease in humans.
- Kizzmekia S. Corbett, PhD, Sr. Research Fellow and Scientific Lead, Coronavirus Vaccines and Immunopathogenesis Team, Vaccine Research Center, NIAID, NIH
Dr. Corbett is the scientific lead for the Coronavirus Vaccines & Immunopathogenesis Team at the National Institutes of Health, National Institute of Allergy and Infectious Diseases, Vaccine Research Center. Her team develops novel coronavirus vaccines, including mRNA-1273, a candidate vaccine against the virus that causes COVID-19. In partnership with Moderna, Inc., this potential vaccine is now in phase 1 clinical trial. Dr. Corbett earned her PhD in microbiology and immunology from UNC.
- Barbara K. Rimer, DrPH, MPH, Dean and Alumni Distinguished Professor, UNC Gillings School of Global Public Health (OPENING REMARKS)
Dr. Rimer has led the Gillings School as dean since 2005 and spends every day concerned about issues such as student recruitment and retention, the relationship between practice and research, and inclusive excellence. She believes that diversity, equity and inclusion in public health and at the Gillings School are essential to best serve the needs of diverse communities in North Carolina and globally.